Journal of Pharmacy and Pharmacology

The challenge of gene therapy and DNA delivery
pp. 1169-1174(6)
Author: Phillips A.J.

New strategies for polymer development in pharmaceutical science–a short review
pp. 1175-1184(10)
Authors: Godwin A.; Bolina K.; Clochard M.; Dinand E.; Rankin S.; Simic S.; Brocchini S.

Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits
pp. 1185-1191(7)
Authors: Miyazaki S.; Kawasaki N.; Endo K.; Attwood D.

The powder flow and compact mechanical properties of two recently developed matrix-forming polymers
pp. 1193-1199(7)
Authors: Hancock B.C.; Carlson G.T.; Ladipo D.D.; Langdon B.A.; Mullarney M.P.

Effectiveness of repeated administration of a new oral naltrexone controlled-release system on morphine analgesia
pp. 1201-1205(5)
Authors: Álvarez-Fuentes J.; Rojas-Corrales M.O.; Holgado M.A.; Sánchez-Lafuente C.; Micó J.A.; Fernández-Arévalo M.

Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats
pp. 1207-1215(9)
Authors: Rodriguez M.; Antúnez J.A.; Taboada C.; Seijo B.; Torres D.

Improved activity and stability of lysozyme at the water/CH₂Cl₂ interface: enzyme unfolding and aggregation and its prevention by polyols
pp. 1217-1226(10)
Authors: Pérez C.; Griebenow K.

Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1–34)
pp. 1227-1234(8)
Authors: Suzuki Y.; Iga K.; Yanai S.; Matsumoto Y.; Kawase M.; Fukuda T.; Adachi H.; Higo N.; Ogawa Y.

Pharmacokinetic–pharmacodynamic modelling of human insulin: validity of pharmacological availability as a substitute for extent of bioavailability
pp. 1235-1246(12)
Authors: Miyazaki M.; Mukai H.; Iwanaga K.; Morimoto K.; Kakemi M.

Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy
pp. 1247-1255(9)
Authors: Fugono J.; Yasui H.; Sakurai H.

Hexarelin–evaluation of factors influencing oral bioavailability and ways to improve absorption
pp. 1257-1264(8)
Authors: Westberg C.; Benkestock K.; Fatouros A.; Svensson M.; Sjo¨stro¨m B.

The use of polymeric solid phase extraction and HPLC analysis for the determination of ranitidine in routine plasma samples obtained from paediatric patients
pp. 1265-1272(8)
Authors: Hare L.G.; Millership J.S.; Collier P.S.; McElnay J.C.; Carson D.J.; Shields M.S.

Monoamine oxidase inhibitory activity of some Hypericum species native to South Brazil
pp. 1273-1279(7)
Authors: Gnerre C.; von Poser G.L.; Ferraz A.; Viana A.; Testa B.; Rates S.M.K.

In-vitro and in-vivo immunomodulatory effects of syringin
pp. 1287-1294(8)
Authors: Cho J.Y.; Nam K.H.; Kim A.R.; Park J.; Yoo E.S.; Baik K.U.; Yu Y.H.; Park M.H.

Inhibition of prostaglandin E₂ production by 2-hydroxychalcone derivatives and the mechanism of action
pp. 1295-1302(8)
Authors: Kim Y.P.; Ban H.S.; Lim S.S.; Kimura N.; Jung S.H.; Ji J.; Lee S.; Ryu N.; Keum S.R.; Shin K.H.; Ohuchi K.

Inhibition of prostaglandin E₂ production by 2-hydroxychalcone derivatives and the mechanism of action
pp. 1295-1302(8)
Authors: Kim Y.P.; Ban H.S.; Lim S.S.; Kimura N.; Jung S.H.; Ji J.; Lee S.; Ryu N.; Keum S.R.; Shin K.H.; Ohuchi K.